LS Podcast banner
Health

State of Life Sciences

Conversations on the future of Pharma and MedTech

Artificial intelligence, and connected healthcare ecosystems, resilient supply chains, evolving commercial models, and modern enterprise platforms are changing how Life Sciences organizations operate and compete.

For leaders across pharmaceutical and MedTech organizations, the challenge is no longer recognising that change is happening. The challenge is deciding where to focus investment, how to accelerate innovation, and how to build organizations that can adapt to continuous disruption.

In this four-part podcast series, industry leaders and Capgemini experts explore the major shifts shaping the future of Life Sciences.

Key topics covered in this series

  • The future of Pharma and MedTech
  • Artificial intelligence in drug discovery and clinical development
  • Connected medical devices and digital health platforms
  • MedTech transformation and connected healthcare ecosystems
  • Supply chain resilience and manufacturing transformation
  • Commercial model innovation in Life Sciences
  • Building a future-ready Life Sciences enterprise

Explore all episodes

The Life Sciences industry is facing growing pressure to innovate faster, improve productivity, manage increasing complexity, and deliver better outcomes for patients.

In this opening episode, Thorsten Rall explores the forces reshaping the industry and introduces the major themes that will define the next decade of transformation across Pharma and MedTech. The discussion examines the changing market landscape, the impact of emerging technologies, and the strategic priorities leaders should focus on today.

Guest:

  • Thorsten Rall, Global Industry Lead Life Sciences, Capgemini

Listen to the episode

Artificial intelligence is rapidly moving from experimentation to real-world application in pharmaceutical research and development.

In this episode, Dr. Alex Zhavoronkov discusses how AI is helping organizations identify new targets, design novel molecules, improve decision-making, and potentially reduce the cost and time required to bring therapies to market. The conversation explores what is achievable today, where the technology is delivering value, and what leaders should be watching next.

Guest:

  • Dr. Alex Zhavoronkov, Founder and CEO, Insilico Medicine

Listen to the episode

Medical technology is evolving far beyond standalone devices.

Increasingly, products combine hardware, software, data, and services to create connected healthcare ecosystems that support clinicians, patients, and care providers. In this episode, we explore how connected medical devices are changing the MedTech landscape, the opportunities created by digital health platforms, and the capabilities organizations need to compete in this new environment.

Guest: Predrag Angelovski, CTO Healthcare Informatics, Philips

Listen to the episode

The final episode steps back from individual technologies and looks at the broader transformation agenda facing Life Sciences leaders.

From manufacturing and supply chain resilience to commercial engagement and enterprise modernisation, organizations are working to become more connected, adaptive, and responsive to change. This conversation brings together the remaining themes from the series and explores how they contribute to building a future-ready Life Sciences enterprise.

Guest: Thorsten Rall, Global Industry Lead Life Sciences, Capgemini

Listen to the episode

About the podcast

The Life Sciences miniseries was developed as part of the Capgemini podcast ‘Realities Remixed’. The podcast explores what happens when people, culture, industry, and technology collide, because real breakthroughs rarely come from technology alone.

Capgemini podcast ‘Realities Remixed’

Meet our expert

Thorsten Rall

Thorsten Rall

Global Industry Lead Life Sciences, EVP
Since January 2023, Thorsten has been the Executive Vice President and Global Industry Lead for Life Sciences at Capgemini. Previously, he worked at Novartis in various senior roles. As Senior Vice President of Digital Transformation & Innovation, he led the digital function, developed and implemented high-risk, high-return strategic innovation initiatives, and was responsible for Business Development and partnerships in the digital space.

    FAQ’s

    The State of Life Sciences is a four-part Capgemini podcast series is part of the Capgemini podcast series ‘Realities Remixed’ and explores the major trends shaping Pharma and MedTech, including artificial intelligence, connected healthcare ecosystems, MedTech platforms, supply chain resilience, commercial transformation, and the future Life Sciences enterprise.

    This series is designed for senior leaders in pharmaceutical, biotechnology, and MedTech organizations who are navigating business transformation, technology adoption, and changing market expectations.

    The series explores artificial intelligence, connected healthcare ecosystems, digital health platforms, resilient supply chains, evolving commercial models, and modern enterprise platforms.

    AI is helping Life Sciences organizations improve discovery, development, decision-making, productivity, and speed to market. The series looks at where AI is already creating value and what leaders should consider next.

    Connected platforms are changing MedTech by bringing together devices, software, data, and services to create more integrated experiences for clinicians, patients, and healthcare providers.

    A future-ready Life Sciences enterprise is more connected, data-driven, adaptive, and resilient. It can respond faster to market change, technology disruption, and evolving patient and healthcare needs.